Melisron (Israel) Performance
| MLSR Stock | ILA 32,200 200.00 0.63% |
On a scale of 0 to 100, Melisron holds a performance score of 16. The company secures a Beta (Market Risk) of 0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Melisron's returns are expected to increase less than the market. However, during the bear market, the loss of holding Melisron is expected to be smaller as well. Please check Melisron's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Melisron's current price movements will revert.
Risk-Adjusted Performance
16 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Melisron are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Melisron sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 967 M | |
| Total Cashflows From Investing Activities | -543 M |
Melisron |
Melisron Relative Risk vs. Return Landscape
If you would invest 2,785,000 in Melisron on August 31, 2024 and sell it today you would earn a total of 435,000 from holding Melisron or generate 15.62% return on investment over 90 days. Melisron is generating 0.3281% of daily returns and assumes 1.5733% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Melisron, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Melisron Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Melisron's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Melisron, and traders can use it to determine the average amount a Melisron's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MLSR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.57 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average Melisron is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Melisron by adding it to a well-diversified portfolio.
Melisron Fundamentals Growth
Melisron Stock prices reflect investors' perceptions of the future prospects and financial health of Melisron, and Melisron fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Melisron Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0317 | |||
| Profit Margin | 0.96 % | |||
| Operating Margin | 0.70 % | |||
| Current Valuation | 22.42 B | |||
| Shares Outstanding | 47.49 M | |||
| Price To Book | 1.27 X | |||
| Price To Sales | 6.96 X | |||
| Revenue | 1.42 B | |||
| EBITDA | 2.44 B | |||
| Cash And Equivalents | 1.29 B | |||
| Cash Per Share | 27.26 X | |||
| Total Debt | 9.2 B | |||
| Debt To Equity | 1.42 % | |||
| Book Value Per Share | 201.44 X | |||
| Cash Flow From Operations | 734 M | |||
| Earnings Per Share | 36.00 X | |||
| Total Asset | 24.54 B | |||
| Retained Earnings | 3.03 B | |||
| Current Asset | 401 M | |||
| Current Liabilities | 1.55 B | |||
About Melisron Performance
By analyzing Melisron's fundamental ratios, stakeholders can gain valuable insights into Melisron's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Melisron has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Melisron has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
The company enhances, manages, maintains, and rents commercial and office spaces. Melisron Ltd. was founded in 1987 and is based in Herzliya, Israel. MELISRON operates under Real Estate Services classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 2266 people.Things to note about Melisron performance evaluation
Checking the ongoing alerts about Melisron for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Melisron help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 52.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Melisron's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Melisron's stock is overvalued or undervalued compared to its peers.
- Examining Melisron's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Melisron's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Melisron's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Melisron's stock. These opinions can provide insight into Melisron's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Melisron Stock analysis
When running Melisron's price analysis, check to measure Melisron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Melisron is operating at the current time. Most of Melisron's value examination focuses on studying past and present price action to predict the probability of Melisron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Melisron's price. Additionally, you may evaluate how the addition of Melisron to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |